IPO Queue for Israel’s Top Missile-Defense Makers Stretches Well Past 2026 as Tomer Joins the List
Rafael, IAI, and now Tomer face a crowded IPO pipeline, with analysts saying no major listing is realistic before 2027.
Three of Israel’s most prominent defense manufacturers — Rafael Advanced Defense Systems, Israel Aerospace Industries, and rocket-motor specialist Tomer — are each eyeing public listings, but a congested pipeline and demanding market conditions mean none are expected to reach the stock exchange before 2027, according to a report by Calcalist Tech. The development is notable for a defense-industrial sector whose products, including the Iron Dome interceptor and the Arrow ballistic-missile defense system, have drawn intense international attention and significant foreign procurement interest in recent years. For observers tracking Israeli defense expansion, the IPO delay signals that capital-markets ambitions are running well ahead of execution capacity.
Rafael, the state-owned company that co-produces Iron Dome with its Iron Dome system partner, and IAI, which leads the Arrow program, have both been discussed as privatization and listing candidates for years. The addition of Tomer — a government-owned entity that manufactures solid-fuel rocket motors and propulsion systems used across multiple Israeli missile programs — further crowds a queue that analysts say the market cannot absorb simultaneously.

Why the Timeline Has Slipped
According to the Calcalist Tech report, the principal obstacle is sequencing: Israeli capital markets and the government entities overseeing these companies cannot realistically prepare, price, and execute multiple large-scale defense IPOs within a compressed window. Each listing requires extensive regulatory preparation, independent valuation of state assets, and coordination with the Israeli government, which retains ownership stakes in all three entities. Those processes, run in parallel, risk cannibalizing investor appetite and depressing valuations.
Market timing adds a second layer of complexity. While the war-driven surge in global defense spending has elevated investor interest in defense equities broadly, translating that interest into a successful Israeli government-enterprise IPO requires stable domestic financial conditions and clear post-conflict visibility into revenue streams — neither of which is fully established at present. Officials have not publicly confirmed a revised target date for any of the three listings, and the Calcalist Tech report characterizes the 2027-or-later horizon as an assessment from people familiar with the process rather than a formal government announcement.
Tomer’s Entry and What It Means for the Queue
Tomer’s emergence as a listing candidate is the newest variable in the equation. The company supplies propulsion systems that underpin multiple programs across the Israeli defense establishment, making it a strategically sensitive asset whose valuation and partial privatization would require careful structuring. Its addition to the IPO conversation suggests Israeli defense planners are casting a wider net around the privatization agenda even as bandwidth constraints push timelines further out.

The sequencing problem has practical industrial consequences. Capital raised through public listings would, in theory, give Rafael, IAI, and Tomer additional resources to expand production capacity at a moment when export orders and domestic procurement demands are both elevated. Delays in accessing that capital could constrain how quickly any of the three companies scales manufacturing — a consideration that extends beyond Israel’s own defense requirements to allies and partners seeking Iron Dome batteries, Arrow interceptors, and associated munitions. How governments and institutional investors ultimately respond when listings do materialize will serve as a meaningful test of whether the recent surge in defense-equity interest translates into durable capital for the sector.
